ORBi: Hanson Julien - In vivo pharmacological evaluation of BM-573, an original thromboxane A2 receptor antagonist and thromboxane synthase inhibitor

Reference : In vivo pharmacological evaluation of BM-573, an original thromboxane A2 receptor antago...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : Pharmacy, pharmacology & toxicology
	To cite this reference:	http://hdl.handle.net/2268/21975

Title :	In vivo pharmacological evaluation of BM-573, an original thromboxane A2 receptor antagonist and thromboxane synthase inhibitor
Language :	English
Author, co-author :	Hanson, Julien [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
	Kolh, Philippe [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path. >]
	Rolin, S. [ > > ]
	Tchana-Sato, Vincent [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie cardio-vasculaire >]
	De Leval, X. [ > > ]
	Petein, M. [ > > ]
	Masereel, B. [ > > ]
	Pirotte, Bernard [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
	Dogné, Jean-Michel [Université de Liège - ULg > Département de pharmacie > Département de pharmacie >]
	Lambermont, B. [ > > ]
	David, J. L. [ > > ]
	Ghuysen, A. [ > > ]
Publication date :	2004
Journal title :	Fundamental & Clinical Pharmacology
Publisher :	Blackwell Science
Special issue title :	18
Pages :	270
Peer reviewed :	Yes (verified by ORBi)
Audience :	International
ISSN :	0767-3981
e-ISSN :	1472-8206
City :	Oxford
Country :	United Kingdom
Permalink :	http://hdl.handle.net/2268/21975

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	F.C.P. 2004 1.pdf		Publisher postprint	106.08 kB	Request copy

All documents in ORBi are protected by a user license.